Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting
Vivoryon Therapeutics N.V. Reports Outcomeof 2026 Annual General MeetingHalle (Saale) / Munich, Germany, September 29, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic dis…